Coronary Stents Market by Product and Service, By Application, By End User and Region
Coronary Stents Market |
The market offers a wide range of stents for
various clinical conditions. A stent implant is typically used to treat cardiac
abnormalities such as blocked blood vessels. In addition, stents are implanted
in the esophagus to allow food and beverages to pass through in patients with
esophageal cancer. They are also inserted in the ureter to prevent kidney urine
flow obstruction, in the gall bladder to allow bile passage in patients with
gall bladder cancer, and in the abdomen and gastrointestinal tract. Metals,
polymers, and natural bioabsorbable materials are commonly used to make
stents.
Rising incidences of cardiovascular diseases
(CVDs) such as stroke and heart attack, as well as an aging population at
increased risk of major cardiac illnesses, are expected to drive demand
for the coronary stents market over the forecast period. The demand for an
effective coronary stent for treatment is expected to rise as the number of
people with CAD rises dramatically. This factor is likely to increase market
demand during the forecasted years. Another factor that is expected to drive
the use of coronary stents market over the forecast period is the increased
desire for minimally invasive procedures (MIS). These treatments have the
advantage of having small incision wounds, which increases patient
satisfaction. These treatments also lead to shorter hospital stays and quicker
recovery times.
In the treatment of coronary heart disease, a
coronary stent is a tube-shaped device that is inserted into the coronary
arteries that supply blood to the heart to keep the arteries open. It is used
in the percutaneous coronary intervention procedure (PCI). Coronary stents are
now used in more than 90% of PCI procedures. Stents have been shown to improve
survival and decrease angina in people who have had a recent myocardial
infarction (chest discomfort). Coronary stents (CS) are expandable tubular
metallic implants that are inserted into atherosclerotic coronary arteries.
Percutaneous coronary intervention (PCI) or coronary angioplasty with stent
placement is the name given to this revascularization procedure. Coronary
dissection and vascular recoil were eliminated with the introduction of
coronary stents market due to the expandable, metallic meshwork that prevents
negative remodeling.
Abbott Laboratories, Medtronic, Inc., Cordis
Corporation, Covidien, Inc., and Boston Scientific Corporation are some of the
major companies involved in the North American coronary stents market.
Comments
Post a Comment